VanEck Associates
EHC icon

VanEck Associates’s Encompass Health EHC Stock Holding History

VanEck Associates’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.81M Buy
87,158
+2,641
+3% +$274K 0.01% 661
2026
Q1 		$8.18M Buy
84,517
+4,404
+5% +$452K 0.01% 650
2025
Q4 		$8.5M Buy
80,113
+2,102
+3% +$244K 0.01% 612
2025
Q3 		$9.91M Buy
78,011
+266
+0.3% +$31.7K 0.01% 551
2025
Q2 		$9.53M Buy
77,745
+71,189
+1,086% +$8.13M 0.01% 502
2025
Q1 		$664K Sell
6,556
-866
-12% -$84.6K ﹤0.01% 1105
2024
Q4 		$685K Sell
7,422
-338
-4% -$33.2K ﹤0.01% 1093
2024
Q3 		$742K Sell
7,760
-2,075
-21% -$186K ﹤0.01% 1037
2024
Q2 		$844K Sell
9,835
-174
-2% -$14.6K ﹤0.01% 1012
2024
Q1 		$827K Buy
+10,009
New +$733K ﹤0.01% 1003
2022
Q1 		– Sell
-19,148
Closed -$994K – 1382
2021
Q4 		$994K Buy
19,148
+2,988
+18% +$154K ﹤0.01% 845
2021
Q3 		$965K Buy
+16,160
New +$1.02M ﹤0.01% 812

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

VanEck Associates's EHC Position: Q2 2026 in Review

VanEck Associates increased its Encompass Health (EHC) stake by 3.1% in Q2 2026, buying an estimated $274K and bringing the position to 87,158 shares worth $8.81M. The position accounts for 0.01% of the portfolio, ranked #661.

VanEck Associates first reported a position in EHC in Q3 2021 and has held it in 12 quarters since. The position peaked at $9.91M in Q3 2025. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • VanEck Associates held 87,158 shares of Encompass Health worth $8.81M as of Q2 2026.
  • VanEck Associates bought 2,641 Encompass Health shares in Q2 2026, an estimated $274K.
  • Encompass Health made up 0.01% of VanEck Associates's portfolio in Q2 2026, its #661 holding.
  • VanEck Associates first reported a position in Encompass Health in Q3 2021 and has held it in 12 quarters since.
  • VanEck Associates's Encompass Health position peaked at $9.91M in Q3 2025.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.